Evidence map›Paper›PMID 27438536›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2017

Primary radical ablative surgery and fibula free-flap reconstruction for T4 oral cavity squamous cell carcinoma with mandibular invasion: oncologic and functional results and their predictive factors.

Olivier Camuzard, Olivier Dassonville, Marc Ettaiche, Emmanuel Chamorey, Gilles Poissonnet, Riadh Berguiga, Axel Leysalle, Karen Benezery, Frédéric Peyrade, Esma Saada and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Mandibular reconstruction in head and neck cancer: which is the gold standard?European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Pooled it
  2. Management of Flap Failure After Head and Neck Reconstruction: A Systematic Review and Meta-analysis.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2022
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Factors associated with survival and patient's quality of life after segmental mandibulectomy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  7. Therapeutic strategies, oncologic and swallowing outcomes and their predictive factors in patients with locally advanced hypopharyngeal cancer.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Olivier CamuzardFace and Neck University Institute, 31 Avenue de Valombrose, 06103, Nice, France.
Olivier DassonvilleFace and Neck University Institute, 31 Avenue de Valombrose, 06103, Nice, France.
Marc EttaicheDepartment of Statistics, Antoine Lacassagne Center, 33 Avenue de Valombrose, 06189, Nice, France.
Emmanuel ChamoreyDepartment of Statistics, Antoine Lacassagne Center, 33 Avenue de Valombrose, 06189, Nice, France.
Gilles PoissonnetFace and Neck University Institute, 31 Avenue de Valombrose, 06103, Nice, France.
Riadh BerguigaFace and Neck University Institute, 31 Avenue de Valombrose, 06103, Nice, France.
Axel LeysalleDepartment of Radiotherapy, Antoine Lacassagne Center, 33 Avenue de Valombrose, 06189, Nice, France.
Karen BenezeryDepartment of Radiotherapy, Antoine Lacassagne Center, 33 Avenue de Valombrose, 06189, Nice, France.
Frédéric PeyradeDepartment of Medical Oncology, Antoine Lacassagne Center, 33 Avenue de Valombrose, 06189, Nice, France.
Esma SaadaDepartment of Medical Oncology, Antoine Lacassagne Center, 33 Avenue de Valombrose, 06189, Nice, France.
Raphael HechemaDepartment of Anaesthesia and Reanimation, Antoine Lacassagne Center, 33 Avenue de Valombrose, 06189, Nice, France.
Anne SudakaDepartment of Pathology, Antoine Lacassagne Center, 33 Avenue de Valombrose, 06189, Nice, France.
Juliette HaudebourgDepartment of Pathology, Antoine Lacassagne Center, 33 Avenue de Valombrose, 06189, Nice, France.
François DemardFace and Neck University Institute, 31 Avenue de Valombrose, 06103, Nice, France.
José SantiniFace and Neck University Institute, 31 Avenue de Valombrose, 06103, Nice, France.
Alexandre BozecFace and Neck University Institute, 31 Avenue de Valombrose, 06103, Nice, France. alexandre.bozec@nice.unicancer.fr.
Centre Antoine Lacassagne · FRInstitut de Chimie de Nice · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of this study were to evaluate clinical outcomes and to determine their predictive factors in patients with oral cavity squamous cell carcinoma (OCSCC) invading the mandibular bone (T4) who underwent primary radical surgery and fibula free-flap reconstruction. Between 2001 and 2013, all patients who underwent primary surgery and mandibular fibula free-flap reconstruction for OCSCC were enrolled in this retrospective study. Predictive factors of oncologic and functional outcomes were assessed in univariate and multivariate analysis. 77 patients (55 men and 22 women, mean age 62 ± 10.6 years) were enrolled in this study. Free-flap failure and local and general complication rates were 9, 31, and 22 %, respectively. In multivariate analysis, ASA score (p = 0.002), pathologic N-stage (p = 0.01), and close surgical margins (p = 0.03) were independent predictors of overall survival. Six months after therapy, oral diet, speech intelligibility, and mouth opening functions were normal or slightly impaired in, respectively, 79, 88, and 83 % of patients. 6.5 % of patients remaining dependent on enteral nutrition 6 months after therapy. With acceptable postoperative outcomes and satisfactory oncologic and functional results, segmental mandibulectomy with fibula free-flap reconstruction should be considered the gold standard primary treatment for patients with OCSCC invading mandible bone. Oncologic outcomes are dependent on three main factors: ASA score, pathologic N-stage, and surgical margin status.

Indexed as

Free Tissue FlapsCarcinoma, Squamous CellFemaleFibulaGraft SurvivalHumansMaleMandibleMargins of ExcisionMiddle AgedMouth NeoplasmsMultivariate AnalysisNeoplasm InvasivenessNeoplasm StagingPlastic Surgery ProceduresRetrospective StudiesFibulaFree-flapHead neck cancerMandibleOral cavityReconstruction

Identifiers

PMID27438536
OpenAlexW2488733937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.